Purpose: Glaucoma is a leading cause of blindness in people of African descent. Minimal data is available from African population-based cohort studies. The primary aims of this study were to describe the normative distribution of glaucoma features to enable glaucoma classification and to assess risk factors for those with glaucoma at follow-up among people aged 50 years and above in Kenya.
G laucoma is a leading cause of blindness globally. 1 The proportion of the worldwide magnitude of blindness attributable to glaucoma increased by 50% between 1990 and 2010 from 4.4% to 6.6%. 2 This trend is expected to continue over coming decades, with the estimated numbers with glaucoma predicted to rise from 60.5 million people in 2010 to 79.6 million by the year 2020 3 and then to 111.8 million by 2040. 4 Glaucoma is the second most common cause of blindness in sub-Saharan Africa (SSA), 5 with estimates suggesting that there were 6.5 million people with glaucoma in SSA in 2010 projected to increase to 8.4 million by 2020, though data are sparse. 3 While blindness from glaucoma may be preventable, this is dependent upon early diagnosis and delivery of longterm effective treatment. Glaucoma poses a particular problem in SSA due to both higher age-specific prevalence, higher risk for open-angle glaucoma, [6] [7] [8] [9] late presentation, 10 and low levels of coverage and adherence with treatment. 11, 12 Adherence to topical treatment is sufficiently poor that the primary treatment of choice in SSA is often surgery 5 in the hope that a single intervention achieves long-term control of intraocular pressure (IOP) as the main modifiable risk factor. [10] [11] [12] Furthermore, clinical features of glaucoma may be different in a SSA setting compared with elsewhere, necessitating different therapeutic approaches.
The objectives of this study were, within the context of a population-based cohort study in Nakuru, Kenya: (i) to describe normative features of glaucoma in this cohort, (ii), to describe the prevalence of glaucoma or specific glaucoma features at baseline and at follow-up, (iii) to assess baseline risk factors for having glaucoma at follow-up, and (iv) to describe clinical signs predictive of glaucoma at follow-up. 13 The distribution of key features of glaucoma [optic nerve morphology, IOP, visual acuity (VA), angle morphology] and the risk factors associated with changing optic disc morphology that occurred over the 6-year follow-up period will also be described.
MATERIALS AND METHODSÈ thics Statement
The London School of Hygiene & Tropical Medicine (LSHTM) Ethics committee and the African Medical Research Foundation (AMREF) granted ethical approval for the study. Approval was also granted by the Provincial Medical Officer for Nakuru County. Written approval was sought from the administrative heads in each cluster, usually the village chief. All participants gave written or thumbprint consent to participate. People requiring medical treatments were referred to the appropriate health care service.
Sampling Strategy and Recruitment
The study baseline fieldwork was carried out between January 2007 and November 2008. The follow-up study took place between October 2012 and March 2014. At baseline, 100 clusters were selected across Nakuru County with a probability proportional to the size of the population using the electoral roll as the sampling frame. A cluster was defined as the area served by a polling station. Households were selected within clusters using a modified compact segment sampling method. 14 Each cluster was divided into segments so that each segment included ∼50 people aged 50 years and above. One segment was selected at random, and all eligible people were included sequentially until 50 had been examined.
The sample size of 5000 people was sufficient to estimate a prevalence of disease at 3.0% among those aged 50 years and above, with a required precision of 0.5%, 95% confidence, a design effect to account for clustering of 1.5, and a response rate of 90% (Epi Info 6.04, Centers for Disease Control and Prevention, Atlanta, GA). In total, 4381 participants were recruited at baseline (response rate 81%). All participants were invited to attend a clinical examination at a central location within the cluster (see below).
Follow-up
Approximately 1 week before the follow-up clinical examination was carried out for a given cluster, a field officer studied the maps of the village including GPS coordinates recorded at baseline and made phone contact with the village chief or guide to arrange the visit. At the planning visit a list of study participants were given to the chief and a local village guide was recruited to assist locating the study participants. Two days before the clinic, the field officer reminded chiefs of the visit by phone and notified them and the guide of the advance team's arrival. On the day before the clinical examination, a study team visited homes of baseline participants and confirmed their identity using National Identity cards and invited them to attend the clinical examination the following day. All identified participants were also asked to help locate baseline participants that had not been found.
On the examination day, the advance team confirmed the identity of participants against data from baseline (age, date of birth, name, and identity cards). In cases of uncertain identity, confirmation was made based on retinal examination verified by comparison of retinal photos with baseline photo (n = 12).
In both baseline and follow-up, a clinical examination was established at a central location where there were appropriate amenities such as electricity, water, and road access. The following examination protocols were implemented at both baseline and follow-up. 13, 15 Ophthalmic and General Examination VA All participants at baseline and follow-up underwent VA testing on each eye separately at 4 m using a reduced LogMAR tumbling "E" chart 16 in an appropriately illuminated area, as described elsewhere. 17, 18 The presenting VA was defined as the number of letters read correctly without glasses if the participant did not have glasses, or with glasses if they had them.
Anterior Segment Examination
At baseline the anterior segment assessment was made on the slit lamp by a single ophthalmologist (W.M.). The Van Herick angle assessment was performed. 19 Anterior Chamber Optical Coherence Tomography (OCT)
Gonioscopic assessment of the angle was not undertaken; however, a Heidelberg slit lamp-adapted optical coherence tomography (SL-OCT) (Heidelberg Engineering, Heidelberg, Germany) was used at baseline to examine the anterior segment to provide population normative data on the angle opening distance, anterior chamber angle (ACA), central corneal thickness, and anterior chamber depth (ACD). These normative data analyses excluded eyes that were pseudophakic. Furthermore, eyes with trachomatous or nontrachomatous corneal opacities and those with disorganized globes (phthisis, staphyloma) were excluded from the corneal thickness analysis. All measurements were obtained from scans using the interactive distance measurement of the SL-OCT proprietary software (Heidelberg Eye Explorer version 1.5.9.0; Heidelberg Engineering). Analyses based on nasotemporal (horizontal) meridians. ACD was assessed using peaks of the corneal reflectivity profile to identify the central cornea as well as the anterior and posterior boundaries of the cornea. Calipers were aligned from the posterior border of the central cornea. Two measurements were averaged for each eye. ACA opening distance was taken as posterior cornea and opposite peripheral iris with the apex lying in the angle recess. All anterior segment measurements were taken with the pupil undilated.
Gonioscopy
At follow-up, an assessment of the opening angle of participants' right and left eyes using direct visualization was made using a 4-mirror gonioscopy lens (Zabbys). This lens does not require coupling fluid and was chosen to minimize impact on the quality of retinal photographs. Angles were recorded using standard Shaffer grading and further classified as "open," "occludable" or "closed" based on standard referral criteria. 20 Angle OCT was not performed at follow-up. Occludable angles were defined at follow-up as: pigmented trabecular meshwork not visible in 3/4 or more of angle circumference in primary position without manipulation, in presence of low illumination. If the patient could not cooperate with gonioscopy, the Van Herick technique 19 was used for grading with an ACD of less than quarter of the corneal thickness being considered occludable.
for the Blind, Eye Drop Production Unit, Nairobi, Kenya) and the tear film stained with fluorescein-impregnated paper. IOP was measured using a Goldmann Applanation Tonometer. One reading was taken from each eye and analyzed independently. The tonometer was checked for calibration weekly and disinfected between patients.
Visual Field (VF) Assessment
At baseline, all individuals with suspect or abnormal discs on clinical slit-lamp examination underwent automated VF testing. The Humphrey Field Analyzer II-720i series (Carl Zeiss Ophthalmic Systems, Oberkochen, Germany) was used. A suspect or abnormal disc was defined as a vertical cup to disc ratio (VCDR) of 0.7 or above; optic disc cupping asymmetry between the eyes of > 0.2 VCDR; or any other abnormal features including notching, disc hemorrhages or disc pallor. A random sample of 5 individuals per cluster (10%) also underwent VF testing to provide normative data.
Participants performed the Swedish Interactive Thresholding Algorithm (SITA) STANDARD 24-2. SITA Fast was used to determine the threshold level in all participants having VF analysis. Appropriate corrective lenses for refractive errors were used when needed. An automated fixation monitor was used throughout. If the SITA fast test was reliable the SITA standard test was performed. If the SITA fast was unreliable (false-positives, ≥ 20%; false-negatives, ≥ 33%; fixation losses, ≥ 33%), then this was repeated once. If it remained unreliable then no further testing was done.
At follow-up, a different strategy for VF testing was used due to challenges at baseline: all subject's eyes with VA equivalent to ≥ 6/60 Snellen underwent automated VF testing by a trained VF technician using the Henson 8000 Visual Field Analyser (TopCon, Tokyo, Japan) The multiple stimulus suprathreshold test was used following the manufacturers' guidelines (Screening test-26 test locations). When one or more spots were missed, the 26-point test was repeated for that eye. If any missed spots reoccurred on the second time of testing the test for that eye was extended to 68 test locations. This machine and strategy were used in preference to the baseline methods due to feedback from both patient's and tester at baseline as well as unreliable VF data from baseline. Patient's found the baseline testing protocol difficult to understand and the time required to complete the test meant only a subsample of the population could be investigated.
VFs were considered consistent with glaucoma at baseline and follow-up if: (1) the test was reliable according to performance indices, (2) the glaucoma hemifield test was outside normal limits, and (3) the test showed 3 or more abnormal contiguous points clustering in the same hemifield.
Visual fields were graded at the Moorfields Eye Hospital Reading Centre.
Fundus Photography and Grading
The participants had 2 nonstereoscopic digital 45 degrees fundus photographs taken per eye by an ophthalmic clinical officer using a TRC-NW6S Non-Mydriatic Retinal Camera with 10 megapixel Nikon D80 (TopCon) at baseline and a DRS CentreVue+ (Haag-Streit, Köniz, Switzerland) Retinal Camera at follow-up. One image was centered on the optic disc while the other was centered on the macula.
The digital images were forwarded to the Retinal Grading Centre at Moorfields Eye Hospital Reading Centre (MEHRC) London for grading and confirming the clinical diagnosis of posterior segment disease.
The senior grader graded all discs considered abnormal on clinical examination at the slit-lamp at baseline and all optic nerve images at follow-up. Images were first categorized for quality as excellent, good, fair, borderline or ungradeable. They were then graded for VCDR. The scleral ring was identified to determine the margins of the disc and delineating the rim identified the cup. The rim was defined as the area between the border of the optic disc and the position of blood vessel bending and the area within the rim as the cup. A vertical measure of both the cup and disc were taken to calculate the VCDR. Discs images were also examined for any abnormality and were graded as normal, suspicious or abnormal. A disc was deemed abnormal if any of neuro-retinal rim thinning, notching or disc hemorrhage(s) were present, if VCDR was ≥ 0.7. A suspicious disc was one where adjudication was necessary to determine if its appearance was abnormal.
In case of difficulties, the adjudicator (T.P.) decided on the grading of the images. The adjudicator also graded 5% of randomly selected images to ensure quality control.
At baseline and follow-up, all participants' discs were estimated based on image grading.
Data Handling and Statistical Analyses Methods

Data entry
Image data were double entered into a specially developed dataset (EpiData Entry version 2.1) at both baseline and follow-up. Consistency checks were performed each evening and inconsistencies corrected the same day.
Data Analysis
The International Society for Geographical & Epidemiological Ophthalmology (ISGEO) categorizes glaucoma as primary open-angle glaucoma (POAG) and primary angle-closure (PAC) based on direct viewing of the angle. POAG is defined in 3 categories based on the optic nerve VCDR, VFs, IOP, VA, and the presence or absence of previous glaucoma surgery (clinically or from medical records). 21 The mean, 97.5th and 99.5th percentiles were calculated for optic disc VCDR and IOP for the participants at follow-up. On the basis of baseline normative data, the cut-off points required for ISGEO POAG classifications were used to classify accordingly: 21 Category 1 with structural and functional evidence: eyes with a VCDR or VCDR asymmetry ≥ 97.5% for the normal population that showed a definite VF defect consistent with glaucoma. Category 2 (advanced structural damage with unproven field loss): eyes of those without any or with no valid VF testing but with a VCDR or asymmetry ≥ 99.5th percentile for the normal population. Category 3 (no view of optic disc and field testing impossible): eyes of those with VA < 3/60 and the IOP > 99.5th percentile, or VA < 3/60 and evidence of glaucoma filtering surgery, or previous diagnosis of glaucoma confirmed from medical records.
Disc suspects: those with VCDR ≥ 97.5th percentile for the population but <99.5th percentile and no other feature of glaucoma and no documented field defect. It also included those with optic disc hemorrhages accompanied by no other feature of glaucoma. Ocular hypertensives: IOP ≥ 97.5th percentile with normaloptic disc and normal VF.
A normative sample was used to calculate the 97.5th and 99.5th percentiles of VCDR and IOP from those participants examined at follow-up with normal VFs.
Baseline to Follow-up Changes
It was not possible to produce an annual glaucoma incidence due to the lack of reliable VF data and therefore it was not possible to define an "at-risk" baseline group. Individuals at follow-up were classified as suspect or definite glaucoma based on the ISGEO criteria using graded images of the optic disc and VFs. Participants at follow-up were then classified in a binary manner as normal or glaucoma (glaucoma if ISGEO categories 1, 2 or 3 were fulfilled for that participant). Multivariable logistic regression analyses were conducted to compare those with and without features of glaucoma at follow-up in terms of baseline demographic, anthropometric and ocular features as potential risk factors of glaucoma.
RESULTS
Follow-up Rates
At baseline (2007 to 2008), 4414 participants had a complete assessment and of these, 2171 (50%) were seen at follow-up 6 years later. Characteristics of participants and nonparticipants at follow-up are described in detail elsewhere. 22, 23 In summary, compared with those followedup, participants who had died during follow-up were older, more likely to be male, to have lower education levels and higher systolic blood pressure and have diabetes, but had lower body mass index. Compared with participants seen, those lost to follow-up (not known to be deceased) were less likely to be Kikuyu or Kalenjin speakers, had lower levels of education, and were more likely to be from urban areas and be from either the highest or lowest socioeconomic quartile.
Anterior Chamber OCT
Anterior segment findings at baseline using OCT are described in Table 1 , the mean angle opening distance (n = 6259) was 631 μm (SD = 167), the mean ACA (n = 3484) was 36.6 degrees (SD = 7.6), the mean central corneal thickness (n = 6365) was 508.1 μm (SD = 36.9), and the mean ACD (n = 6358) was 2.67 mm (SD = 0.32).
Gonioscopy
Anterior segment OCT was not available at follow-up; however, 2111 right eyes and 2107 left eyes had a direct visualization of the angle using a 4-mirror gonioscope, with only 5 right and 5 left eyes (0.2%) considered to have occludable angles (based on visualization of Schwalbe's line and the anterior meshwork or less) ( Table 2 ).
IOP
The mean IOP at baseline based on 3745 observations (right eye only) was 15.3 mm Hg (SD = 3.4, range = 2 to 46 mm Hg). Of these, there were 1775 observations (right eyes only) for whom IOP was measured at both baseline and follow-up. Among these, at baseline mean IOP was 15.4 (SD = 3.4) for the right eye, and at follow-up (right eyes) was 15.0 mm Hg (SD = 3.2, range = 1 to 34 mm Hg), providing evidence of a lower IOP at follow-up compared with baseline among right eyes (P < 0.001). IOP was significantly higher in the right eye than the left eye at both baseline (P < 0.001) and follow-up (P = 0.02) ( Table 3) .
Optic Discs
At baseline, due to camera failure preventing image acquisition in one third of clusters, a slit-lamp based clinical assessment of the optic disc VCDR was made in 2 ways: (1) Through undilated pupils with +90 D lenses using slitlamp biomicroscopy (n = 5917 eyes). (2) After dilating pupils with +90 D lenses using slit-lamp biomicroscopy (n = 7821 eyes).
Baseline optic disc assessment is summarized in Table 4 . A total of 1063 (25.7%) right eye discs and 1078 (25.8%) left eye discs could not be visualized with undilated pupils. There was a statistically significant difference between the mean VCDR for eyes with pupils dilated and nondilated pupils where the disc was visible in both instances, with the dilated eyes having higher VCDR ratios (0.23, SD = 0.15) than nondilated eyes (0.21, SD = 0.13) (paired t test <0.001). Using undilated CDR 1.5% of eyes had CDR ≥ 0.7 while using dilated CDR, 2.8% of eyes had VCDR ≥ 0.7 (χ 2 = 13.8, P = 0.002). At follow-up, the VCDR for right and left eyes from image grading were available in all clusters from 3658 of a possible 4342 eyes (2171 people). The median VCDR was 0.3 and at the 97.5th and 99.5th percentile it was 0.7 and 0.8, respectively (Fig. 1) .
The VCDR percentiles at follow-up in those with a normal VF (n = 1062) remained at 0.7 and 0.8 at the 97.5th and 99.5th percentiles, respectively. At baseline, 3251 participants had a clinical assessment (ie, no image grading) of the optic discs, of which 40 (1.2%) were considered abnormal, 536 (16.5%) suspicious and 2,675 (82.3%) normal. At follow-up, 2003 participants had an image-based assessment of the optic discs, of which 64 (3.2%) were graded as abnormal, 234 (11.7%) suspicious, and 1705 (85.1%) were normal. A total of 89 of 1255 (7.1%) participants who had a baseline (clinical) and follow-up (image) assessment went from "normal" to either "suspicious" or "abnormal." Of the 1499 participants who had optic discs graded at both baseline (clinical) and follow-up (image) 17l (1.1%) were considered abnormal, 236 (15.7%) suspicious, and 1246 (83.1%) as normal at baseline. At follow-up there were 53 (3.5%) considered abnormal, 174 (11.6%) suspicious, and 1272 (84.9%) normal.
VFs
Interpretation based on VFs was not possible at baseline. A total of 508 participants (glaucoma suspects and nonglaucoma suspects) were indicated for VF testing at baseline of whom 342 (67.3%) completed the test on the Humphrey Visual Field Analyser. Of these, 63.2% and 69.1% of normal and glaucoma suspects had abnormal VF results despite good reliability indices. These baseline results were therefore discarded.
At follow-up, 1309 (60.3%) participants successfully completed fields on the Henson 8000 Field Analyser with reliable results. 1074 (82.0%) were normal in both eyes, 122 (9.3%) had one or both eyes with suspicious fields and 113 (8.6%) had an abnormal field in one or both eyes.
On the basis of gradable optic disc images at follow-up in those with normal VFs, the 97.5th and 99.5th percentile VCDRs were 0.7 and 0.8, respectively (Fig. 1) .
Signs of Glaucoma
At follow-up, 1246 individuals had a VF measurement and a disc grading. Of these, 895 (71.8%) had both a normal VF and a normal disc, 141 (11.3%) had a normal VF and suspicious or abnormal disc, 182 (14.6%) had a suspicious or abnormal VF and normal discs and 28 (2.2%) had both suspicious or abnormal VFs and suspicious or abnormal discs.
Using the ISGEO classification 88 participants were considered to have glaucoma based on meeting either the ISGEO 1 (n = 64), 2 (n = 22) or 3 (n = 2) criteria, 1973 participants did not meet ISGEO criteria and were deemed nonglaucoma, 110 could not be classified (Fig. 2) .
On the basis of follow-up optic disc grading from images, VFs, IOP and VA, participants were defined as glaucoma positive or negative based on the ISGEO criteria. Vision status comparing participants with and without ISGEO glaucoma are described in Table 5 showing participants with glaucoma were more likely to have visual impairment. In all, 85.2% of the nonglaucoma group classified as normal vision, compared with 72.7% in the glaucoma group. Blindness and VI were more prevalent in the glaucoma group, 5.7% and 21.6%, respectively, compared with those without glaucoma, 1.2% and 13.6%, respectively. Baseline and follow-up risk analyses was conducted and is summarized in Table 6 . There was some evidence of an association of glaucoma with sex [male as baseline, female odds ratio (OR), 0.69; 95% confidence interval (CI), 0.45-1.06; P = 0.10). No evidence of an association was found between baseline IOP and body mass index (P = 0.49), height (P = 0.58), and weight (P = 0.28). Associations of glaucoma with ophthalmic signs at follow-up were seen for both IOP (IOP > 21 mm HG OR, 4.10; 95% CI, 2.08-8.08; P < 0.001) and a relative afferent pupillary defect (RAPD) showing a particularly strong association with being categorized as glaucoma (Confirmed RAPD OR, 7.39; 95% CI, 4.20-13.01; P < 0.001).
DISCUSSION
In this study we have described the population distributions and normative ranges from an epidemiological survey of glaucoma in an East African population in Kenya. Structural damage manifest by optic nerve changes was comparable in terms of the population distribution to other studies (described below). In those with glaucoma at followup, the strongest predictors were the presence at follow-up of an RAPD and IOP above 21 mm Hg. No demographic or anthropometric risk factors were associated with glaucoma.
The prevalence of glaucoma on those followed up was 4.3% (CI, 3.5-5.9) which is comparable to other populationbased studies in Africa which range from 4.2% (3.5-4.9) to 7.3% (5.5-9.1) 24,25 with a higher prevalence in west African populations [Nigeria 5.0% (4.6-5.5) and 7.3% (5.5-9.1), 25 Ghana 6.5% (5.8-7.1) 26 ] than is East and Southern African populations [Tanzania 4.2% (3.5-4.9), 24 South Africa 4.5% (3.2-6.1) 27 and 5.3% (3.9-7.1) 28 ].
The basis of the diagnosis of glaucoma in the majority of cases, both in clinical settings and in population-based surveys, is correlation of structural optic nerve damage and loss of function demonstrated by VF testing. 21 However, in SSA, where equipment constraints are considerable, 29 VF testing is not widely available. A survey in Lagos State, Nigeria identified one VF analyzer for every 2,380,000 population including private and governmental facilities. 30 Even where field analyzers are available, they are of much less importance in the diagnosis and treatment decision making process than in more resource intense settings; VF changes were a factor in only 4% of treatment decisions in a review of 344 patients attending a glaucoma clinic in South African. 31 Population-based studies have demonstrated that there are substantial difficulties in achieving adequate field testing in SSA populations. 32 The lack of a reliable VF in the baseline of this cohort is consistent with other studies in the region that have faced similar challenges such as the Nigerian National Blindness Survey that used a relatively simple testing modality, the Humphrey Frequency Doubling Technology test, where adequate testing was only available for 60% of 4538 Nigerian patients. 32 Furthermore, the logistical problems obtaining reliable VF tests mean that they were not included in the flow chart for community diagnosis of glaucoma in a recently published West African algorithm; relative afferent pupillary defect testing was the chosen test of nerve function, 33 which the findings of this study concur with.
Diagnosis and management of glaucoma in SSA, therefore, centers very much around IOP and optic nerve assessment, the latter through direct visualization and pupil assessment. Very little data from longitudinal populationbased cohorts exist, with none to date from SSA, on glaucoma. This cohort study of people aged 50+ undertaken in Nakuru, Kenya, with baseline in 2007 to 2008 and follow-up in 2013 to 2014 was an opportunity to estimate the normative range of various features of glaucoma as well as potential features that are important for clinical decision making in a context where availability of equipment is limited.
The percentile distributions of optic nerve VCDR and IOP in the Nakuru Cohort follow-up subgroup in whom 34 Our findings are also consistent with other population-based studies in the region where a VCDR of 0.7 was consistent at the 97.5th percentile; however, greater variation is found at the 99.5th from 0.7 in Tanzania to 0.9 in South Africa. 24, [26] [27] [28] The IOP distribution in Kenya was similar at baseline and follow-up with a higher median than in Nigeria (15 vs. 14 mm Hg) but lower IOP at the 97.5th and 99.5th percentiles (Kenya: 22, 27 mm Hg vs. Nigeria: 24, 34 mm Hg). 34 Changes over the period of the cohort were difficult to define conclusively due to the clinical nature of a glaucoma diagnosis; however, a strong association between optic discs and VFs considered to be outside of normal range was demonstrated, in particular with the RAPD test. An IOP over 21 mm Hg was also less strongly associated with glaucoma as defined by the ISGEO criteria in this study. The findings suggest a combination of optic nerve assessment by both visualization including VCDR grading as well assessing function through the RAPD test are practical means for identifying individuals who have or are at risk of sight loss from glaucoma. Portable tools for assessing vision 18 and optic disc imaging 35 may make this more accessible with IOP being a suitable method to monitor an effect from treatment and various handheld tools now available for accurate IOP assessment independent of a slit lamp.
Management of glaucoma remains a major challenge in SSA with limited availability and poor adherence to medical treatment when available. A primary surgical approach has problems also, in that patients presenting due to visual loss in 1 eye need to be persuaded to undergo surgery, most frequently with direct financial costs to them, in the other eye which they do not as yet consider to have a problem. 10, 36 The operation of choice, trabeculectomy augmented by anti-metabolites, does not improve the vision in most cases, but in fact can lead to visual acuity reduction. Identification of new treatment options in Africa therefore remains a priority.
Strengths of this study included it being a large, population-based sample, representative of a population on which there is minimal data. A senior ophthalmologist examined all study participants at baseline and follow-up. High quality, modern, equipment was used throughout.
Limitations included a high loss to follow up (50%) at 6 years, this was primarily due to postelection violence affecting the study population with large numbers of people displaced or killed. Major variations in baseline and followup data collection protocols were used, in part due to challenges at baseline such as unreliable VF data, retinal camera break down and due to a lack of availability of all baseline equipment at follow-up, for example, no repeat AC-OCT was undertaken. Key measurement differences and therefore potential measurement bias were (i) likely with VFs at baseline being completed for glaucoma suspects (n = 165) and a subset of normal participants (n = 343) (11.6% of all baseline participants) only and using a Humphrey Field Analyser with outputs that could not be confidently used to make an assessment of glaucoma, the Henson 8000 was used at follow-up, (ii) ACA assessment at baseline was based on AC-OCT and on 4-mirror gonioscopy at follow-up, (iv) a statistically significant variation between right and left eye IOP at baseline and follow up. IOP was on average higher in the right than the left eye at both baseline and follow-up. This may have arisen because the right eye was tested first and/or because the majority of the population was assumed to be right-handed, and IOP measurement is associated with hand dominance. 37, 38 In conclusion, glaucoma remains a public health concern. However, the lack of cost-effective treatments and challenges identifying high-risk individuals means that population-based screening for open-angle glaucoma should not currently be recommended. 39 Further research in to the risk factors, natural history and etiology of glaucoma in Africa and the barriers to effective sight loss prevention are required.
